Skip to content Skip to footer
Subscribe Now
Viewpoint_Kimberly_Smith_2020
VIEWPOINTS

PharmaShots Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020

In a recent interview with PharmaShots, Kimberly Smith, MD, MPH, Head of Research & Development at ViiV Healthcare shared information on the positive findings presented at the 2020 Infectious Diseases Society of America (IDWeek) and the impact of COVID-19 on the development of long-acting cabotegravir and rilpivirine.Shots:The company reported the positive findings of a pooled…
December 28, 2020

Read more

VIEWPOINTS

PharmaShots Interview: Neoleukin’s Daniel-Adriano Silva Shares Insight on Novel Protein Designed to Treat or Block SARS-COV-2

In a recent interview with PharmaShots Daniel-Adriano Silva, PhD, Co-founder and Vice President Head of Research at Neoleukin shared the significance and promise of the findings published in Science and discuss the details of its De Novo Protein DesignShots:NL-CVX1 (CTC-445.2d) demonstrated the ability to prevent infection of multiple human cell lines in vitro and to protect…
December 18, 2020

Read more

Viewpoint_Noreen_Heng_2020
VIEWPOINTS

PharmaShots Interview: Kezar’s Noreen Henig Shares Insight on Therapeutic Potential of KZR-616

In a recent interview with PharmaShots, Noreen Henig, Chief Medical Officer at Kezar Life Sciences shared information on clinical and pre-clinical data supporting the potential of KZR-616 to positively affect multiple drivers of immune-mediated diseases.Shots:The poster presented at ACR 2020 includes additional patient-weeks of safety and tolerability data compared to prior data presentations for our…
December 17, 2020

Read more

Viewpoint_Fabian_Gerlinghaus_2020
VIEWPOINTS

PharmaShots Interview: Cellares’ Fabian Gerlighaus Shares Insight on Cell Shuttle

In a recent interview with PharmaShots, Fabian Gerlighaus, Co-Founder and CEO of Cellares, shared information on Cellares partnership with Fred Hutchinson Cancer Research Center and unveils how the company is working to get patients the cell therapies they need.Shots:Cellares collaboration with Fred Hutchinson Cancer Research Center is a part of EAPP. Fred Hutch will work closely…
December 14, 2020

Read more

ViewPoint_William_F_Doyle_2020
VIEWPOINTS

PharmaShots Interview: Novocure’s William F. Doyle Shares Insight on Company’s Accomplishments in the Treatment of Glioblastoma and Mesothelioma

In a recent interview with PharmaShots, William F. Doyle, Executive Chairman at Novocure shared information about the company's activities in the field of glioblastoma and mesothelioma. He also discussed the company's technology, Tumor Treating Fields (TTFields), and its potential for broad applicability across solid tumors.Shots:Novocure is a global oncology company working to extend survival…
December 9, 2020

Read more

Viewpoints_Andrea Taylor
VIEWPOINTS

PharmaShots Interview: Duke’s Andrea Taylor Shares Insight on Launch And Scale Speedometer

In a recent interview with PharmaShots, Andrea Taylor, Researcher at Launch And Scale  Speedometer shared her insights and highlights on data how rich countries shopping spree for COVID-19 vaccines means fewer vaccinations for billions in low-income countriesShots:The Launch and Scale Speedometer project aims to systematically analyze the factors that support or hinder the introduction and scaling of interventions,…
December 8, 2020

Read more

Load more